Polomar Health Services swings to net income of US$174,981 in 1H FY26; revenue rises to US$2.53 million in 1H FY26

• Polomar Health Services reported Q2 revenue of US$1.53 million, up US$1.52 million from a year earlier on higher prescription volume.
• Gross profit climbed to US$935,916, lifting gross margin to 61.2%.
• General and administrative expense fell 53.1% to US$261,120, mainly on lower depreciation and amortization.
• Sales and marketing expense rose to US$456,419 from US$10,507, driven by commissions and higher shipping and fulfillment costs.
• Plans call for launching SlimRx, a weight-loss telehealth platform, in Q3 2026 to drive prescription volume fulfilled by Polomar Pharmacy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polomar Health Services Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038324), on August 14, 2026, and is solely responsible for the information contained therein.